In life sciences, we are all swimming in a sea of information.
We have access to a staggering amount of data that was unimaginable even 5 years ago—and demand for data and information remains high even with the recent economic slowdown.
ClinicalTrials.gov lists more than 400,000 studies worldwide in 2022, compared to about 2,000 in the year 2000.
Over the past decade, the number of medical publications has grown by 86%.
The number of pharma and biotech company…
Host and President of TGaS Advisors, Gary McWalters, joins a panel of four experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the key themes that were discussed at the TGaS Fall Client Summit – an annual event that brings together leaders in life sciences to discuss innovative solutions to the common challenges faced within commercial operations.
HOST: Gary McWaltersHost and President of TGaS Advisors
Kim WoodhourField Operations Director
Brian VoellmeckeCommercial Data Management Leader
As the market becomes increasingly crowded and budget constraints continue in China, downward pricing pressure to secure National Reimbursement Drug List (NRDL) inclusion remains the top challenge for multinational pharma companies in this market. However, the significant uptake post-NRDL inclusion and broad access offer substantial opportunities for innovative products with clinical differentiation.
In this white paper, Trinity Life Sciences explores the highlights of the 2021 NRDL negotiation; including trends within the oncology, rare disease and chronic disease therapeutic areas…
Many life sciences companies design customer engagement models that rely on coordination and communication between Account Managers, Sales, Reimbursement, Patient Services, and Field Medical to drive outcomes, performance, continuity and improve the customer and patient experience. These collaborative field teams are often formally or informally referred to as matrix or matrix-based field teams, and tend to be organized by Integrated Delivery Networks (IDNs), ecosystems and/or geography.
Executive stakeholders from Field Leadership, Brands and Market Access functions have shared during benchmark…
During the past two years we have witnessed an accelerating race to evolve digital and data capabilities through enhancement of tech stacks to make organizations more analytically driven and connected moving forward. With issues such as data privacy and a cookie-less world at the forefront, it is now incumbent upon brands to unify data and to understand how independent efforts come together to impact customers.
At TGaS/Trinity Life Sciences, the Omnichannel Solution is deeply connected across…
This advisory brief incorporates learnings from TGaS Advisors’ 2022 Fall Summit, which brought together the industry’s top commercial operations, market access and medical affairs executives to discuss the hottest trends, address concerns and prepare for future challenges.
More than 200 individuals from 100 emerging, mid-tier and large-tier biopharmaceutical companies attended function-specific sessions across the Commercial, Market Access and Medical Affairs ecosystem. Leaders shared perspectives, made recommendations and collectively thought through alternative paths forward relative to key decisions to be made…
November 7, 2022
The Oncology Care Model (OCM) was designed to test whether financial incentives can improve care and lower Medicare (U.S. federal health insurance program) spending, emphasizing value-based care within oncology treatment. This model supported a wide range of services such as high-cost emergency room visits, 24/7 access to clinicians and specialized, patient-specific coordinated care plans.The Enhancing Oncology Model (EOM) builds on the structure of OCM with an increased focus on managing provider risk, promoting patient-centric care…
Now Available On Demand:
Trinity invites life sciences executives to join us for a dynamic discussion on the most common high-impact challenges inherent in Business Development:
What contributes to inaccurate pricing and market access assumptions in the quick-paced Business Development process?
How do you de-risk pricing and access at each stage of the diligence process?
Chad Faulkner, Partner in Trinity’s Strategic Advisory practice, will host this session and moderate a panel with special guests Monica Martin De Bustamante—Senior Partner &…
Now Available On Demand:
What are the latest incentive compensation trends that you need to know to remain competitive in the quest for talent?
TGaS Advisors, a division of Trinity Life Sciences, explored this question as part of our 12th Annual Incentive Compensation Landscape – the most comprehensive study of its kind in the life sciences industry. We surveyed Incentive Compensation (IC) leaders at 54 life sciences companies of all sizes to gain their perspectives on current trends and best…
October 31, 2022
Germany’s ‘Financial Stabilization of Statutory Health Insurance System’ Act (GKV-Finanzstabilisierungsgesetz) was first proposed in March 2022 by Health Minister Professor Karl Lauterbach to help tackle the country’s economic deficit
As of October 2022, the act was adopted by the Bundestag (German Federal Parliament). The act is expected to be implemented by January 2023
The new Statutory Health Stabilization Act includes several measures with significant impact in the commercial opportunity for pharmaceutical products
Key Policy Updates…